Shanghai Fosun Pharmaceutical (group) Co., Ltd. - Net Worth and Insider Trading

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Net Worth

The estimated net worth of Shanghai Fosun Pharmaceutical (group) Co., Ltd. is at least $44 Million dollars as of 2024-12-27. Shanghai Fosun Pharmaceutical (group) Co., Ltd. is the 10% Owner of Natures Sunshine Products Inc and owns about 2,918,774 shares of Natures Sunshine Products Inc (NATR) stock worth over $44 Million. Details can be seen in Shanghai Fosun Pharmaceutical (group) Co., Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shanghai Fosun Pharmaceutical (group) Co., Ltd. has not made any transactions after 2024-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Shanghai Fosun Pharmaceutical (group) Co., Ltd.

To

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shanghai Fosun Pharmaceutical (group) Co., Ltd. owns 2 companies in total, including Natures Sunshine Products Inc (NATR) , and ContraFect Corp (CFRXQ) .

Click here to see the complete history of Shanghai Fosun Pharmaceutical (group) Co., Ltd.’s form 4 insider trades.

Insider Ownership Summary of Shanghai Fosun Pharmaceutical (group) Co., Ltd.

Ticker Comapny Transaction Date Type of Owner
NATR Natures Sunshine Products Inc 2024-10-15 10 percent owner
CFRXQ ContraFect Corp 2017-07-25 10 percent owner

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Latest Holdings Summary

Shanghai Fosun Pharmaceutical (group) Co., Ltd. currently owns a total of 1 stock. Shanghai Fosun Pharmaceutical (group) Co., Ltd. owns 2,918,774 shares of Natures Sunshine Products Inc (NATR) as of October 15, 2024, with a value of $44 Million.

Latest Holdings of Shanghai Fosun Pharmaceutical (group) Co., Ltd.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NATR Natures Sunshine Products Inc 2024-10-15 2,918,774 15.17 44,277,802

Holding Weightings of Shanghai Fosun Pharmaceutical (group) Co., Ltd.


Shanghai Fosun Pharmaceutical (group) Co., Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Shanghai Fosun Pharmaceutical (group) Co., Ltd. has made a total of 2 transactions in Natures Sunshine Products Inc (NATR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Natures Sunshine Products Inc is the sale of 2,300 shares on October 15, 2024, which brought Shanghai Fosun Pharmaceutical (group) Co., Ltd. around $29,946.

Insider Trading History of Shanghai Fosun Pharmaceutical (group) Co., Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Ownership Network

Ownership Network List of Shanghai Fosun Pharmaceutical (group) Co., Ltd.

No Data

Ownership Network Relation of Shanghai Fosun Pharmaceutical (group) Co., Ltd.

Insider Network Chart

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Owned Company Details

What does Natures Sunshine Products Inc do?

Who are the key executives at Natures Sunshine Products Inc?

Shanghai Fosun Pharmaceutical (group) Co., Ltd. is the 10 percent owner of Natures Sunshine Products Inc. Other key executives at Natures Sunshine Products Inc include Pres Nature's Sunshine Int'l Bryant J Yates , EVP & President & Asia Daniel C Norman , and EVP & General Counsel Nathan G Brower .

Natures Sunshine Products Inc (NATR) Insider Trades Summary

Over the past 18 months, Shanghai Fosun Pharmaceutical (group) Co., Ltd. made 2 insider transaction in Natures Sunshine Products Inc (NATR) with a net sale of 13,195. Other recent insider transactions involving Natures Sunshine Products Inc (NATR) include a net sale of 27,236 shares made by Daniel C Norman , a net sale of 18,068 shares made by Bryant J Yates , and a net sale of 3,999 shares made by Nathan G Brower .

In summary, during the past 3 months, insiders sold 13,195 shares of Natures Sunshine Products Inc (NATR) in total and bought 0 shares, with a net sale of 13,195 shares. During the past 18 months, 62,498 shares of Natures Sunshine Products Inc (NATR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 62,498 shares.

Natures Sunshine Products Inc (NATR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Natures Sunshine Products Inc Insider Transactions

No Available Data

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Shanghai Fosun Pharmaceutical (group) Co., Ltd.. You might contact Shanghai Fosun Pharmaceutical (group) Co., Ltd. via mailing address: Building A, No. 1289 Yishan Road, Shanghai F4 200233.

Discussions on Shanghai Fosun Pharmaceutical (group) Co., Ltd.

No discussions yet.